Philippe Berthon
Partner
Philippe works as an Operating Partner at DNA Finance and is currently CEO of Blue Bees Therapeutics, an immuno-oncology biotech company.
He has held several leadership positions as CEO in biotech and medtech: CEO of Culture Top (sold to Eurofins in 2021), Tridek One, Aurgalys (sold to Genesta / In Extenso in 2018), Vaxon-Biotech and UroGene (sold to Pierre Fabre in 2004). He cofounded and led the Research Urology Dept. at Hospital St Louis in Paris until 1999. As such, he has a strong background in strategic planning, financing, operations, business development, and R&D with over 50 international scientific publications.
Philippe holds a PhD in Reproductive Physiology from Pierre-et Marie Curie / Sorbonne University) and a Business Administration degree from HEC.